Abstract:Abstract Cell-free protein synthesis (CFPS) is a widely used research tool in systems and synthetic biology. However, if CFPS is to become a mainstream technology for applications such as point of care manufacturing, we must understand the performance limits and costs of these systems. Toward this question, we used sequence specific constraint based modeling to evaluate the performance of E. coli cell-free protein synthesis. A core E. coli metabolic network, describing glycolysis, the pentose phosphate pathway, energy metabolism, amino acid biosynthesis and degradation was augmented with sequence specific descriptions of transcription and translation and effective models of promoter function. Model parameters were largely taken from literature, thus the constraint based approach coupled the transcription and translation of the protein product, and the regulation of gene expression, with the availability of metabolic resources using only a limited number of adjustable model parameters. We tested this approach by simulating the expression of two model proteins: chloramphenicol acetyltransferase and dual emission green fluorescent protein, for which we have training data sets; we then expanded the simulations to a range of additional proteins. Protein expression simulations were consistent with measurements for a variety of cases. The constraint based simulations confirmed that oxidative phosphorylation was active in the CAT cell-free extract, as without it there was no feasible solution within the experimental constraints of the system. We then compared the metabolism of theoretically optimal and experimentally constrained CFPS reactions, and developed parameter free correlations which could be used to estimate productivity as a function of protein length and promoter type. Lastly, global sensitivity analysis identified the key metabolic processes that controlled CFPS productivity and energy efficiency. In summary, sequence specific constraint based modeling of CFPS offered a novel means to a priori estimate the performance of a cell-free system, using only a limited number of adjustable parameters. While we modeled the production of a single protein in this study, the approach could easily be extended to multi-protein synthetic circuits, RNA circuits or the cell free production of small molecule products.

Computer-Based Design of a Cell Factory for High-Yield Cytidine Production

Modularized Reconstruction of Pyrimidine Pathway in Escherichia Coli for Enhanced Pyrimidine Nucleosides Biosynthesis

Deoxycytidine production by a metabolically engineered Escherichia coli strain

Multistep construction of metabolically engineered Escherichia coli for enhanced cytidine biosynthesis

Improving the level of the cytidine biosynthesis in E. coli through atmospheric room temperature plasma mutagenesis and metabolic engineering

Increased Distribution of Carbon Metabolic Flux During De Novo Cytidine Biosynthesis Via Attenuation of the Acetic Acid Metabolism Pathway in Escherichia Coli

Combinatorial Optimization of MEP Pathway to Improve β-Carotene Yield

Enhanced Cytidine Production by a Recombinant Escherichia Coli Strain Using Genetic Manipulation Strategies

Enhancement of Cytidine Production by Coexpression of Gnd, Zwf, and Prs Genes in Recombinant Escherichia Coli Cyt15

In silico-guided metabolic engineering of Bacillus subtilis for efficient biosynthesis of purine nucleosides by blocking the key backflow nodes

Production of pyrimidine nucleosides in microbial systems via metabolic engineering: Theoretical analysis research and prospects

Metabolic engineering of Escherichia coli for optimized biosynthesis of nicotinamide mononucleotide, a noncanonical redox cofactor

Cytoophidia: a conserved yet promising mode of enzyme regulation in nucleotide metabolism

Computational Biology Predicts Metabolic Engineering Targets for Increased Production of 102 Valuable Chemicals in Yeast

Sequence Specific Modeling of E. coli Cell-Free Protein Synthesis

[Metabolic engineering of Escherichia coli for thymidine production]

The Effect of E. Coli Uridine-Cytidine Kinase Gene Deletion on Cytidine Synthesis and Transcriptome Analysis

Deoxycytidine production by metabolically engineered Corynebacterium ammoniagenes

Reconstruction of the Genome-Scale Metabolic Model of Saccharopolyspora erythraea and Its Application in the Overproduction of Erythromycin

The New Strategy of Breeding Cytidine Excessive Biosynthesis Mutants by pyr Operon Rearrangement of Bacillus amyloliquefaciens

Redistribution of Intracellular Metabolic Flow in E. Coli Improves Carbon Atom Economy for High-Yield 2,5-Dimethylpyrazine Production